Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

Ye Jiang,Mahmuda Yeasmin,Arisbel B. Gondin,Arthur Christopoulos,Celine Valant,Wessel A. C. Burger,David M. Thal

DOI: https://doi.org/10.1111/bph.16021

IF: 7.3

2022-12-24

British Journal of Pharmacology

Abstract:Background and Purpose Affinity‐based selective muscarinic acetylcholine receptor (mAChR) orthosteric ligands are difficult to develop due to high sequence homology across the five receptor subtypes. Selectivity can also be achieved via the selective activation of a particular subtype or signalling pathway. Promisingly, a prior study identified compounds 6A and 7A as functionally selective and Gi biased compounds at the M2 mAChR. Here, we have investigated the activation of individual G protein subfamilies and the downstream signalling profiles of 6A and 7A at the M2 mAChR. Experimental Approach G protein activation was measured with the TRUPATH assay in M2 mAChR FlpIn CHO cells. Activity in downstream signalling pathways was determined using the cAMP CAMYEL BRET sensor and the extracellular signal‐regulated kinase 1/2 phosphorylation assay. Key Results M2 mAChR coupled to Gɑi1, GɑoA and Gɑs, but not Gɑq, in response to canonical orthosteric agonists. Compounds 6A and 7A did not elicit any G protein activation, cAMP inhibition or stimulation, or ERK 1/2 phosphorylation. Instead, a Schild analysis indicates a competitive, antagonistic interaction of compounds 6A and 7A with ACh in the Gɑi1 activation assay. Overexpression of the M2 mAChR may suggest an expression dependent activation profile of 6A and 7A. Conclusions and Implications These data validate that the M2 mAChR preferentially couples to Gɑi/o and to a lesser extent to Gɑs in response to canonical orthosteric ligands. However, this study was not able to detect Gɑi bias of compounds 6A and 7A highlighting the importance of cellular background when classifying new ligands.

pharmacology & pharmacy